1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 285 F.Supp.3d
  5. 285 F.Supp.3d 351 (2018)
 

AMGEN INC. v. HARGAN

Civil Action No. 17-1006 (RDM).

285 F.Supp.3d 351 (2018)

AMGEN INC., Plaintiff, v. Eric D. HARGAN, Acting Secretary, Department of Health and Human Services, et al., Defendants, and Teva Pharmaceuticals USA, Inc., et al., Intervenor-Defendants.

United States District Court, District of Columbia.

Signed January 26, 2018.

Editors Note
Applicable Law: 05 U.S.C. § 0706
Cause: 05 U.S.C. § 0706 Judicial Review of Agency Actions
Nature of Suit: 890 Other Statutory Actions
Source: PACER

Attorney(s) appearing for the Case

Catherine Emily Stetson, Susan Margaret Cook, Hogan Lovells U.S. LLP, Washington, DC, for Plaintiff.

Charles John Biro, U.S. Department of Justice, Washington, DC, for Defendants.

Douglas B. Farquhar, Hyman, Phelps & McNamara, P.C., William M. Jay, Brian Burgess, Prescott Moore Lassman, Goodwin Procter, LLP, Washington, DC, Joshua James Bone, Goodwin Procter LLP, Boston, MA, for Intervenor-Defendants.

MEMORANDUM OPINION AND ORDER

To encourage pharmaceutical companies to study the safety and effectiveness of pediatric uses of drugs approved for adults, the Federal Food, Drug, and Cosmetic Act ("FFDCA") grants six months of "pediatric exclusivity" to the sponsor of...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases